ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Aberrant GRP78 Phase Transition Sustains Endothelial IRE1α Signaling and Drives Blood-Brain Barrier Failure in Cerebral Amyloid Angiopathy.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Cerebral amyloid angiopathy (CAA) is a major cause of vascular cognitive impairment and lobar intracerebral hemorrhage, yet the mechanisms by which vascular amyloid-beta (Aβ) disrupts cerebrovascular integrity remain poorly defined. Here, we combined spatiotemporal single-cell and single-nucleus transcriptomics in APP23 mice with mechanistic studies in human brain endothelial cells and validation in human CAA-related hemorrhagic tissues to define the endothelial stress pathways driving disease progression. Endothelial cells emerged as an early and highly vulnerable vascular population during CAA development, characterized by persistent activation of endoplasmic reticulum (ER) stress programs with preferential engagement of the IRE1α branch. In vitro, Aβ40 preformed fibrils directly induced ER remodeling, aberrant solid-like phase transition of GRP78, sustained IRE1α-TRAF2-JNK signaling, endothelial apoptosis, and tight junction loss. In vivo, pharmacological inhibition of IRE1α with 4µ8C restored junctional integrity, reduced blood-brain barrier leakage, attenuated vascular amyloid pathology, and improved behavioral performance. Human CAA-related intracerebral hemorrhage specimens recapitulated endothelial ER stress, apoptotic activation, and tight junction depletion. These findings identify persistent endothelial IRE1α signaling as a key driver of cerebrovascular failure in CAA, highlighting its potential as a therapeutic target for vascular amyloidosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.